0001950101-22-000001.txt : 20221108 0001950101-22-000001.hdr.sgml : 20221108 20221108103139 ACCESSION NUMBER: 0001950101-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221108 DATE AS OF CHANGE: 20221108 EFFECTIVENESS DATE: 20221108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nuago Therapeutics, Inc. CENTRAL INDEX KEY: 0001950101 IRS NUMBER: 873683959 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-464163 FILM NUMBER: 221367648 BUSINESS ADDRESS: STREET 1: 875 NORTH MICHIGAN AVENUE STREET 2: SUITE 3100 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 773-401-3203 MAIL ADDRESS: STREET 1: 875 NORTH MICHIGAN AVENUE STREET 2: SUITE 3100 CITY: CHICAGO STATE: IL ZIP: 60611 D 1 primary_doc.xml X0708 D LIVE 0001950101 Nuago Therapeutics, Inc. 875 NORTH MICHIGAN AVENUE SUITE 3100 CHICAGO IL ILLINOIS 60611 773-401-3203 DELAWARE None None Corporation true 2020 Dr. Robert Schickel 875 North Michigan Avenue Suite 3100 Chicago IL ILLINOIS 60611 Executive Officer Director Dr. Andrea E. Murmann 875 North Michigan Avenue Suite 3100 Chicago IL ILLINOIS 60611 Executive Officer Director Dr. Marcus E. Peter 875 North Michigan Avenue Suite 3100 Chicago IL ILLINOIS 60611 Director Biotechnology Decline to Disclose 06b false 2022-10-25 false true false 0 3600000 150000 3450000 false 4 0 0 0 false Nuago Therapeutics, Inc. /s/ Dr. Robert Schickel Dr. Robert Schickel Chief Executive Officer 2022-11-08